Dr. Robert Cava, M.D,
What this data tells you about Dr. Cava
Dr. Robert Cava is a critical care medicine in Coral Gables, FL, with 20 years in practice. Based on federal Medicare data, Dr. Cava performed 6,512 Medicare services across 1,850 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cava received a total of $27 from 1 pharmaceutical and/or device company across 1 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cava is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,005 | $18 | $23 |
| Blood draw (venipuncture) | 552 | $8 | $25 |
| Office visit, established patient (20-29 min) | 460 | $70 | $181 |
| Chronic care management, first 20 min/month | 420 | $51 | $86 |
| Office visit, established patient (30-39 min) | 372 | $97 | $239 |
| Steroid injection (triamcinolone) | 268 | $1 | $10 |
| Urinalysis, manual | 201 | $3 | $24 |
| Electrocardiogram (EKG), 12-lead | 132 | $12 | $75 |
| Flu vaccine administration | 108 | $33 | $35 |
| Flu vaccine, high-dose | 107 | $71 | $93 |
| Annual wellness visit, follow-up | 103 | $135 | $150 |
| COVID-19 vaccine administration | 96 | $43 | $50 |
| COVID-19 vaccine (Pfizer bivalent) | 85 | $127 | $150 |
| Drug injection, under skin or into muscle | 85 | $11 | $40 |
| Annual alcohol misuse screening, 5 to 15 minutes | 70 | $19 | $28 |
| Adm sarscv2 bvl 50mcg/.5ml a | 63 | $43 | $49 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 60 | $35 | $88 |
| Home visit, established patient, moderate complexity | 53 | $95 | $250 |
| Joint injection, major joint | 47 | $49 | $153 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 42 | $18 | $35 |
| Chest X-ray, 2 views | 38 | $27 | $75 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 31 | $41 | $100 |
| Detection test by immunoassay with direct visual observation for influenza virus | 28 | $16 | $30 |
| Chronic care management, additional 20 min/month | 27 | $39 | $65 |
| Heart rhythm recording of continous external ekg over 8-15 days | 17 | $10 | $45 |
| Removal of impacted ear wax | 15 | $39 | $83 |
| Pneumonia vaccine administration | 15 | $33 | $35 |
| Echocardiogram, transthoracic | 12 | $148 | $360 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
Associated products mentioned in payments ›
The majority of payments (100%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in critical care medicine and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Cava is a clinical cardiology specialist, with above-average Medicare volume (top 3% in FL), and speaking/promotional industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Cava experienced with denosumab injection (prolia/xgeva)?
Does Dr. Cava receive payments from pharmaceutical companies?
How do Dr. Cava's costs compare to other critical care medicines in Coral Gables?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology